Article Versions Notes

Noskova H, Kyr M, Pal K, Merta T, Mudry P, Polaskova K, Ivkovic TC, Adamcova S, Hornakova T, Jezova M, et al. Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision? Cancers. 2020; 12(1):230. https://doi.org/10.3390/cancers12010230

Noskova, Hana, Michal Kyr, Karol Pal, Tomas Merta, Peter Mudry, Kristyna Polaskova, Tina Catela Ivkovic, Sona Adamcova, Tekla Hornakova, Marta Jezova, and et al. 2020. "Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?" Cancers 12, no. 1: 230. https://doi.org/10.3390/cancers12010230

Noskova, H., Kyr, M., Pal, K., Merta, T., Mudry, P., Polaskova, K., Ivkovic, T. C., Adamcova, S., Hornakova, T., Jezova, M., Kren, L., Sterba, J., & Slaby, O. (2020). Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision? Cancers, 12(1), 230. https://doi.org/10.3390/cancers12010230